His main research concerns Biochemistry, Oxidative phosphorylation, Mitochondrion, Glycolysis and Cell biology. Biochemistry and Kinetics are two areas of study in which Rafael Moreno-Sánchez engages in interdisciplinary work. His work carried out in the field of Oxidative phosphorylation brings together such families of science as Fructose, Phosphorylation, Oligomycin, Dehydrogenase and Respiratory chain.
The concepts of his Mitochondrion study are interwoven with issues in Cancer cell, Reactive oxygen species, ATP synthase and Pharmacology. His biological study spans a wide range of topics, including Flux, Bioenergetics and Heart disease. His Cell biology research is multidisciplinary, incorporating perspectives in Carcinogenesis, Cancer and Apoptosis.
Biochemistry, Oxidative phosphorylation, Mitochondrion, Glycolysis and Euglena gracilis are his primary areas of study. His Biochemistry and Enzyme, Glutathione, Metabolism, ATP synthase and Respiratory chain investigations all form part of his Biochemistry research activities. His work in Oxidative phosphorylation addresses subjects such as Cell biology, which are connected to disciplines such as Cancer cell and Transcription factor.
In his research, Reactive oxygen species is intimately related to Oxidative stress, which falls under the overarching field of Mitochondrion. His study in Glycolysis is interdisciplinary in nature, drawing from both Entamoeba histolytica, Flux and Carbohydrate metabolism. The Euglena gracilis study combines topics in areas such as Photosynthesis, Biophysics, Alternative oxidase, Euglena and Cadmium.
Rafael Moreno-Sánchez spends much of his time researching Biochemistry, Cancer cell, Glycolysis, Cancer research and Enzyme. His works in Glutathione, Metabolism, Mitochondrion, Phosphorylation and Citric acid cycle are all subjects of inquiry into Biochemistry. The study incorporates disciplines such as Paclitaxel, Cisplatin, Therapeutic index and Doxorubicin in addition to Cancer cell.
His Glycolysis study combines topics in areas such as Oxidative phosphorylation and Cell biology. His Oxidative phosphorylation research is multidisciplinary, relying on both Cell growth and NAD+ kinase. While the research belongs to areas of Enzyme, he spends his time largely on the problem of Metabolite, intersecting his research to questions surrounding Amino acid, GPX4, Reactive oxygen species, Respiratory chain and Glutamine.
Rafael Moreno-Sánchez focuses on Oxidative phosphorylation, Biochemistry, Glycolysis, Cancer cell and Mitochondrion. As part of his studies on Oxidative phosphorylation, Rafael Moreno-Sánchez frequently links adjacent subjects like Citric acid cycle. He combines subjects such as Cell growth, Entamoeba histolytica, Carbohydrate metabolism, Anaerobic bacteria and NAD+ kinase with his study of Glycolysis.
As a member of one scientific family, Rafael Moreno-Sánchez mostly works in the field of Cancer cell, focusing on Cancer research and, on occasion, Cancer, Celecoxib, Apoptosis, Cancer stem cell and Mitochondrial ROS. His Mitochondrion study which covers Metabolism that intersects with Oxidative stress, HeLa, Resveratrol and Lipid peroxidation. His Glutathione study combines topics from a wide range of disciplines, such as Photosynthesis, Cell type, Euglena gracilis and Nickel.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Interactions of chromium with microorganisms and plants
Carlos Cervantes;Jesús Campos-García;Silvia Devars;Félix Gutiérrez-Corona.
Fems Microbiology Reviews (2001)
Energy metabolism in tumor cells
Rafael Moreno‐Sánchez;Sara Rodríguez‐Enríquez;Alvaro Marín‐Hernández;Emma Saavedra.
FEBS Journal (2007)
HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Alvaro Marin-Hernandez;Juan C. Gallardo-Perez;Stephen John Ralph;Sara Rodriguez-Enriquez.
Mini-reviews in Medicinal Chemistry (2009)
Sulfur assimilation and glutathione metabolism under cadmium stress in yeast, protists and plants.
David Mendoza-Cózatl;Herminia Loza-Tavera;Andrea Hernández-Navarro;Rafael Moreno-Sánchez.
Fems Microbiology Reviews (2005)
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Stephen John Ralph;Sara Rodríguez-Enríquez;Jiri Neuzil;Jiri Neuzil;Emma Saavedra.
Molecular Aspects of Medicine (2010)
Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense STEADY-STATE ADP FORMATION AS A REGULATORY MECHANISM OF MEMBRANE POTENTIAL AND REACTIVE OXYGEN SPECIES GENERATION IN MITOCHONDRIA
Wagner Seixas da-Silva;Armando Gómez-Puyou;Marietta Tuena de Gómez-Puyou;Rafael Moreno-Sanchez.
Journal of Biological Chemistry (2004)
Heart metabolic disturbances in cardiovascular diseases.
Karla Carvajal;Rafael Moreno-Sánchez.
Archives of Medical Research (2003)
Determining and understanding the control of glycolysis in fast‐growth tumor cells
Alvaro Marín‐Hernández;Sara Rodríguez‐Enríquez;Paola A. Vital‐González;Fanny L. Flores‐Rodríguez.
FEBS Journal (2006)
Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II
Lan-feng Dong;Victoria J. A. Jameson;David Patrice Tilly;Jiri Cerny.
Journal of Biological Chemistry (2011)
Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger
Stephen John Ralph;Sara Rodríguez-Enríquez;Jiri Neuzil;Jiri Neuzil;Rafael Moreno-Sánchez.
Molecular Aspects of Medicine (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: